WinstonWınston
RHÖN-KLINIKUM Aktiengesellschaft logo

RHÖN-KLINIKUM Aktiengesellschaft

RHK.DE
39
Medical - Care Facilities · Healthcare
Price
€13.20
-0.10 (-0.75%)
Market Cap
€883.6M
Exchange
Frankfurt Stock Exchange
Winston Score
39
Winston is serious
Below-average fundamentals — multiple weak pillars.

Rhoen-Klinikum AG is a German hospital company that runs a network of large acute-care hospitals and medical centers. It provides services like surgery, emergency care, and specialized treatments to patients across Germany. The company is one of the larger private hospital operators in Germany, with a focus on high-complexity medical care rather than routine outpatient services.

Rhoen-Klinikum earns money primarily by billing health insurers — both public and private — for the medical treatments its hospitals deliver. It operates almost entirely within Germany, and its main competitive advantage is its concentration in regional hospital hubs that handle complex cases other smaller facilities cannot. However, the company faces real pressure: its gross margin is currently negative, meaning it costs more to deliver care than it collects in direct revenues before overhead, which reflects the broader challenge German hospitals face from rising staff costs, energy prices, and reimbursement rates that have not kept pace with inflation.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+5.2% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+72.7% YoY

YoY Growth Rate

EPS growth accelerating

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

94.5%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Position

Cash flow positive

$160M cash & investments

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

RHÖN-KLINIKUM Aktiengesellschaft is growing revenue at 5% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Share count broadly stable

0.0% over 4y

The share count has stayed roughly flat over this period — little dilution or buyback activity.

Diluted shares outstanding: 66.9M (2021) → 66.9M (2025)

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
-3.5%
Thin — -3.5% gross margin
Operating Margin
3.7%
Thin — 3.7% operating margin
ROCE
1.1%
Weak — 1.1% return on capital

ROIC between 0% and 5%. They earn a few cents back per dollar invested in the business.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
+6.1%
Slow sales growth (6.1% YoY)
EPS YoY
+1.7%
Flat earnings

Single-digit earnings growth — steady but not exciting.

EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
0%
Weak — only 0% of profit becomes cash
FCF Margin
0.0%
Thin free cash flow (0.0%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
0.08
Conservative — low debt load (0.08)
Interest Cover
15.89x
Comfortably covers interest (15.9x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
22.0x
Growth-priced — P/E 22.0

P/E above the market average. People are paying up for expected growth.

P/E vs Forward
+6.3
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (22.0 → 15.7)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend Yield
1.43%
Small dividend — 1.43% yield

Modest yield. The bulk of any return needs to come from price appreciation.

Dividend Growth
-65.9%
Dividend cut (-65.9% YoY) — warning sign

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial